XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
3.140
+0.120 (3.97%)
Apr 2, 2025, 4:00 PM EDT - Market closed
XBiotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 172.68 | 200.02 | 157.31 | 236.98 | 237.37 | Upgrade
|
Short-Term Investments | - | - | 60.17 | - | - | Upgrade
|
Cash & Short-Term Investments | 172.68 | 200.02 | 217.48 | 236.98 | 237.37 | Upgrade
|
Cash Growth | -13.67% | -8.03% | -8.23% | -0.16% | -66.78% | Upgrade
|
Accounts Receivable | - | - | - | - | 4.11 | Upgrade
|
Other Receivables | 0.86 | 0.94 | 1.76 | 8.95 | 6.57 | Upgrade
|
Receivables | 0.86 | 0.94 | 1.76 | 8.95 | 10.69 | Upgrade
|
Prepaid Expenses | 1.03 | 0.76 | 0.6 | 0.93 | 0.58 | Upgrade
|
Other Current Assets | - | - | - | - | 77.24 | Upgrade
|
Total Current Assets | 174.57 | 201.72 | 219.84 | 246.87 | 325.88 | Upgrade
|
Property, Plant & Equipment | 24.53 | 24.9 | 26.26 | 28.31 | 27.34 | Upgrade
|
Long-Term Deferred Tax Assets | - | - | - | - | 0.53 | Upgrade
|
Total Assets | 199.09 | 226.62 | 246.1 | 275.18 | 353.74 | Upgrade
|
Accounts Payable | 2.22 | 2.52 | 2.41 | 2.07 | 2.49 | Upgrade
|
Accrued Expenses | 2.63 | 3.5 | 1.6 | 1.37 | 1.35 | Upgrade
|
Short-Term Debt | 10.25 | - | - | - | - | Upgrade
|
Current Income Taxes Payable | - | 0.08 | 0.06 | 0.01 | 0.14 | Upgrade
|
Total Current Liabilities | 15.11 | 6.1 | 4.07 | 3.45 | 3.98 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 0.06 | 0.87 | - | Upgrade
|
Other Long-Term Liabilities | 1.72 | 1.67 | 1.58 | 1.47 | 1.12 | Upgrade
|
Total Liabilities | 16.83 | 7.77 | 5.7 | 5.79 | 5.11 | Upgrade
|
Common Stock | 273.11 | 271.15 | 267.33 | 262.26 | 249.81 | Upgrade
|
Retained Earnings | -90.84 | -52.31 | -27.75 | 5.15 | 97.57 | Upgrade
|
Comprehensive Income & Other | - | - | 0.83 | 1.97 | 1.27 | Upgrade
|
Shareholders' Equity | 182.27 | 218.85 | 240.4 | 269.39 | 348.64 | Upgrade
|
Total Liabilities & Equity | 199.09 | 226.62 | 246.1 | 275.18 | 353.74 | Upgrade
|
Total Debt | 10.25 | - | - | - | - | Upgrade
|
Net Cash (Debt) | 162.43 | 200.02 | 217.48 | 236.98 | 237.37 | Upgrade
|
Net Cash Growth | -18.80% | -8.03% | -8.23% | -0.16% | -66.78% | Upgrade
|
Net Cash Per Share | 5.33 | 6.57 | 7.14 | 7.89 | 7.70 | Upgrade
|
Filing Date Shares Outstanding | 30.49 | 30.45 | 30.44 | 30.44 | 29.46 | Upgrade
|
Total Common Shares Outstanding | 30.49 | 30.44 | 30.44 | 30.44 | 29.3 | Upgrade
|
Working Capital | 159.46 | 195.62 | 215.78 | 243.42 | 321.89 | Upgrade
|
Book Value Per Share | 5.98 | 7.19 | 7.90 | 8.85 | 11.90 | Upgrade
|
Tangible Book Value | 182.27 | 218.85 | 240.4 | 269.39 | 348.64 | Upgrade
|
Tangible Book Value Per Share | 5.98 | 7.19 | 7.90 | 8.85 | 11.90 | Upgrade
|
Land | 1.42 | 1.42 | 1.42 | 1.42 | 1.42 | Upgrade
|
Buildings | 24.17 | 24.17 | 24.17 | 22.77 | 21.01 | Upgrade
|
Machinery | 17.03 | 16.89 | 16.57 | 17.6 | 15.2 | Upgrade
|
Construction In Progress | 1.71 | 0.47 | 0.4 | 2.06 | 2.63 | Upgrade
|
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.